Sepsis caused by Listeria monocytogenes related with the use of infliximab [3];Sepsis por Listeria monocytogenes asociada al uso de infliximab

Medicina Clinica

Volumn 124, Issue 10, 2005, Pages 398-

  De La Fuente Penco, Belén ^a   Piella, Antoni Marcó ^a   Riera Mestre, Antoni ^a   Boadas Mir, Jaume ^a  

^a HOSPITAL DE TERRASSA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; INFLIXIMAB; METHOTREXATE; METRONIDAZOLE; PREDNISONE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

CROHN DISEASE; DRUG USE; HUMAN; INTESTINE BIOPSY; LETTER; LISTERIA MONOCYTOGENES; LISTERIOSIS; SEPSIS; SIGMOIDOSCOPY;

EID: 20244389242     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13072579     Document Type: Letter

References (10)

1. Mulero J, Vera M. Infliximab y etanercept hoy. Inf Ter Sist Nac Salud. 2003;27:168-74.
2. Sandborn WJ, Hanauer SB. Infliximab in the treatment of Crohn's disease: a user's guide for clinicians. Am J Gastroenterol. 2002;97:2962-72.
3. Ramos-González A, Corzo-Delgado JE, Sánchez-Burson J. Tuberculosis miliar en un paciente con artritis reumatoide tratado con infliximab. Med Clin (Barc). 2002;119:636-7.
4. Slifman NR, Gershon SK, Lee J-H, Edwards ET, Miles M. Listeria monocytogenes infection as a complication of treatment with tumor necrosis factor α-neutralizing agents. Arthritis Rheum. 2003;48:319-24.
5. Garcia A, Muñoz-Fernández S, Bonilla G, Miralles A, Cerdeño V, Martín-Mola E. Report of an additional case of anti-tumor necrosis factor therapy and Listeria monocytogenes infection: comment on the letter by Glück et al. Arthritis Rheum. 2003;48:1764-6.
6. Stephens MC, Shepanski MA, Mamula P, Markowitz JE, Brown KA, Baldassano RN. Safety and steroid-sparing experience using infliximab for Crohn's disease at a pediatric inflammatory bowel disease center. Am J Gastroenterol. 2003;98:104-11.
7. Glück T, Linde H-J, Schölmerich J, Müller-Ladner U, Fiehn C, Bohland P. Anti-tumor necrosis factor therapy and Listeria monocytogenes infection: report of two cases. Arthitis Rheum. 2002;46:2255-7.
8. Joosten AA, Van Olffen GH, Hageman G. Meningitis due to Listeria monocytogenes as a complication of Infliximab therapy. Ned Tijdschr Geneeskd. 2003;147:1470-2.
9. Brown WR. Listeria: the latest putative pathogenic microorganism In Crohn's disease. Gastroenterology. 1995;108:1598-90.
10. Molina J, Núñez O, Beceiro I, Marín T, Pérez-Calle JL. Romboencefalitis por Listeria monocytogenes como complicacies de la enfermedad de Crohn. Gastroenterol Hepatol. 2003;26:456-60.